NONO

Information NONO

Description

This gene encodes an RNA-binding protein which plays various roles in the nucleus, including transcriptional regulation and RNA splicing. A rearrangement between this gene and the transcription factor E3 gene has been observed in papillary renal cell carcinoma. Alternatively spliced transcript variants have been described. Pseudogenes exist on Chromosomes 2 and 16. [provided by RefSeq, Feb 2009]

Full Name

non-POU domain containing octamer binding

Source NCBI

ReMap Statistics

Datasets
6
Biotypes
3
Peaks
56,329
Non-redundant peaks
41,107

TF Classification

Super Class
Yet undefined DNA-binding domains
Class
NonO domain factors
Familly
NonO-related factors
Sub Familly
None

Source TFClass

External IDs

JASPAR
Ensembl
ENSG00000147140
UniProt
Q15233
Genevisible
Q15233
RefSeq
NM_001145408
Aliases
MRXS34; NMT55; NRB54; P54; P54NRB; PPP1R114
All peaks NONO
Download BED file
Non redundant peaks NONO
Download BED file
SEQUENCES NONO
Download FASTA file
DOWNLOAD All ReMap
Got to catalogue

Datasets Table for NONO

Target name Target modification Ecotype/Strain Biotype Biotype modification Source Species Experiment Peaks
NONO Hep-G2 ENCODE Homo sapiens ENCSR476BQA 3,608
NONO Hep-G2 ENCODE Homo sapiens ENCSR923UTX 20,252
NONO K-562 ENCODE Homo sapiens ENCSR010KFT 14,318
NONO K-562 ENCODE Homo sapiens ENCSR415TXN 7,595
NONO K-562 ENCODE Homo sapiens ENCSR886RYH 6,034
NONO MCF-7 ENCODE Homo sapiens ENCSR912NMR 4,522
Target name Target modification Ecotype/Strain Biotype Biotype modification Source Species Experiment Peaks

ReMap is a database of transcriptional regulators peaks derived from curated ChIP-seq, ChIP-exo, DAP-seq experiments in Human and Thaliana.

You are using the 2020 ReMap (3rd) release.
The ReMap catalogues (2020, 2018, 2015) are under CC BY-NC 4.0 international license, while ReMapEnrich, remap-pipeline under GNU GPLv3 licence.

Inserm TAGC
AMU AMU-MESO

This work was granted access to the HPC resources of Aix-Marseille Université financed by the project Equip@Meso (ANR-10-EQPX-29-01) of the program "Investissements d’Avenir" supervised by the Agence Nationale de la Recherche.